The global hereditary angioedema therapeutics market size was estimated at USD 3.3 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. Growing cases of hereditary angioedema (HAE) globally is a key growth driver for the market. Accor... Read More »
September 2023The global biopharmaceutical excipients market size was valued at USD 2.45 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.50% from 2023 to 2030. Increasing R&D investments in biosimilars, coupled with the patent expiration of top-selling biologic... Read More »
September 2023The Africa generic pharmaceutical market size was estimated at USD 6.43 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.32% from 2023 to 2030. The market is poised to experience significant growth opportunities driven by several factors. With a growi... Read More »
September 2023The U.S. aromatherapy market size was estimated at USD 626.6 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.0% from 2023 to 2030. Growing awareness about the therapeutic benefits of essential oils is one of the primary drivers for market growth. Ess... Read More »
September 2023The global peptide drug conjugates (market size was valued at USD 590.56 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 28.58% from 2023 to 2030. The robust clinical trial pipeline with peptide drug conjugates (PDCs) coupled with increase in R&D in... Read More »
September 2023The global carbapenem market size was valued at USD 3.62 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.78% from 2023 to 2030. The rise in antibiotic-resistant bacterial infections has been a major driver for the demand for carbapenems market. Moreov... Read More »
September 2023The global actinic keratosis treatment market size was estimated at USD 6.4 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030. The market is anticipated to witness growth opportunities owing to factors such as the rising prevalen... Read More »
September 2023The global myeloproliferative disorders drugs market size was valued at USD 7.35 billion in 2017. It is expected to grow at a compound annual growth rate (CAGR) of 3.4% from 2018 to 2023. The U.S. dominated was at the forefront of the seven major markets. The availability of novel ... Read More »
September 2023The global hemoglobinopathies market size was valued at USD 8.28 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2023 to 2030. The increasing prevalence of conditions such as sickle cell disease and thalassemia, strong product pipeline for tr... Read More »
September 2023The U.S. specialty injectable generics market size was estimated at USD 19.23 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.33% from 2023 to 2030. The demand for specialty generic drugs has increased significantly due to a rise in the prevalence of ... Read More »
September 2023The North America opioids market size was estimated at USD 14.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 0.8% from 2023 to 2030. The demand for opioids in the North America region has witnessed significant growth over the years, primarily fueled ... Read More »
September 2023The U.S. sex reassignment hormone therapy market size was estimated at USD 1.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.05% from 2023 to 2030. The market growth is attributed to the increasing efforts by key market players in developing highl... Read More »
August 2023The global nutritional supplements market size was estimated at USD 381.47 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2030. Growing attention to health has significantly helped the market thrive. Moreover, the rising prevalence of... Read More »
August 2023The Asia Pacific multi-cancer early detection market size was estimated at USD 172.68 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.84% from 2023 to 2030. The multi-cancer early detection (MCED) market is witnessing growth due to the increasing hea... Read More »
August 2023The global pruritus therapeutics market size was estimated at USD 8.39 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030. The growing prevalence of conditions associated with pruritus such as atopic dermatitis, urticaria, and psoriasis is expected to serve t... Read More »
August 2023The global mouth ulcer treatment market size was estimated at USD 1.52 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030. Rising awareness regarding oral hygiene and the increasing geriatric population are anticipated to drive th... Read More »
August 2023The global narcolepsy therapeutics market size was estimated at USD 3.28 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.85% from 2023 to 2030. Narcolepsy is a lifelong sleep disorder with sudden uncontrollable sleep attacks and affects every aspect o... Read More »
August 2023The non-injectable insulin market comprises various insulin formulations designed for administration without injections. These alternatives offer options for individuals with diabetes who face challenges with conventional injection techniques or have allergies to injections. Non-injectab...Read More »
The growth of the global biosimilar monoclonal antibodies (mAbs) market can be attributed to various factors which include increasing patent expiries of monoclonal antibodies, advancements in mAbs innovation, increasing demand for cost-efficient products, the rising prevalence of chronic...Read More »
Cryptococcosis, caused by Cryptococcus neoformans and Cryptococcus gattii fungi, primarily affects individuals with weakened immune systems, including those with HIV/AIDS or who have undergone organ transplantation. The infection is typically acquired through inhaling dust containing yea...Read More »